{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:08:50Z","timestamp":1774976930322,"version":"3.50.1"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The DANIsh VASculitis cohort study, DANIVAS, is an observational national multicenter study with the overall aim to prospectively collect protocolized clinical data and biobank material from patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) diagnosed and\/or followed at Danish rheumatology departments. A long-term key objective is to investigate whether the use of new clinically implemented diagnostic imaging modalities facilitates disease stratification in the GCA-PMR disease spectrum. In particular, we aim to evaluate treatment requirements in GCA patients with and without large-vessel involvement, treatment needs in PMR patients with and without subclinical giant cell arteritis, and the prognostic role of imaging with respect to aneurysm development. Hence, in GCA and PMR, imaging stratification is hypothesized to be able to guide management strategies. With an established infrastructure within rheumatology for clinical studies in Denmark, the infrastructure of the Danish Rheumatologic Biobank, and the possibility to cross-link data with valid nationwide registries, the DANIVAS project holds an exceptional possibility to collect comprehensive real-world data on diagnosis, disease severity, disease duration, treatment effect, complications, and adverse events. In this paper, we present the research protocol for the DANIVAS study.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical trial registration<\/jats:bold>\n                    :\n                    <jats:ext-link>https:\/\/clinicaltrials.gov\/<\/jats:ext-link>\n                    , identifier NCT05935709.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2024.1415076","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T01:36:21Z","timestamp":1719970581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumatica"],"prefix":"10.3389","volume":"11","author":[{"given":"Berit D.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salome","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnete","family":"Donskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Terslev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene Wohlfahrt","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Colic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pil","family":"H\u00f8jgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torkell","family":"Ellingsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Chrysidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kresten K.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00259-018-4106-0","article-title":"Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study","volume":"46","author":"Nielsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1016\/S2665-9913(21)00246-0","article-title":"Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study","volume":"3","author":"Chrysidis","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/rheumatology\/keu191","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"53","author":"Patil","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7861\/clinmed.2022-0415","article-title":"Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis","volume":"23","author":"Smith","year":"2023","journal-title":"Clin Med (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/rheumatology\/kez568","article-title":"Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET \/ CT as the reference","volume":"59","author":"Nielsen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e003379","DOI":"10.1136\/rmdopen-2023-003379","article-title":"Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations","author":"Bosch","year":"2023","journal-title":"RMD Open"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"63","author":"De Miguel","year":"2023","journal-title":"Rheumatology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica","volume":"83","author":"De Miguel","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref14","article-title":"Characterising polymyalgia rheumatica on whole-body 18 F-FDG PET\/CT: an atlas","author":"Owen","year":""},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/rheumatology\/keaa646","article-title":"New insights into the role of imaging in polymyalgia rheumatica","volume":"60","author":"Camellino","year":"2021","journal-title":"Rheumatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/rheumatology\/keac713","article-title":"An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists","volume":"62","author":"Donskov","year":"2023","journal-title":"Rheumatology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"105185","DOI":"10.1016\/j.jbspin.2021.105185","article-title":"Fast track clinic for early diagnosis of polymyalgia rheumatica: impact on symptom duration and prednisolone initiation","volume":"88","author":"Fr\u00f8lund","year":"2021","journal-title":"Joint Bone Spine"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(23)01310-7","article-title":"Polymyalgia rheumatica","volume":"402","author":"Esp\u00edgol-Frigol\u00e9","year":"2023","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225134","article-title":"Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group","author":"Krarup Keller","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41927-021-00210-6","article-title":"The fast-track outpatient clinic significantly decreases hospitalisation rates among polymyalgia rheumatica patients","volume":"5","author":"Chrysidis","year":"2021","journal-title":"BMC Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.rdc.2023.03.005","article-title":"Giant cell arteritis and polymyalgia Rheumatica: treatment approaches and new targets. Rheumatic disease","volume":"49","author":"Nepal","year":"2023","journal-title":"Clin North America"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kez672","article-title":"British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis","volume":"59","author":"MacKie","year":"2020","journal-title":"Rheumatology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"Recommendations for the management of polymyalgia rheumatica: a European league against rheumatism\/American College of Rheumatology collaborative initiative","volume":"2015","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.semarthrit.2021.01.007","article-title":"Giant cell arteritis: a nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment","volume":"51","author":"Therkildsen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"105494","DOI":"10.1016\/j.jbspin.2022.105494","article-title":"Epidemiology and predictors of relapse in giant cell arteritis: a systematic review and meta-analysis","volume":"90","author":"Moreel","year":"2023","journal-title":"Joint Bone Spine"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/rheumatology\/keab507","article-title":"All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study","volume":"61","author":"Therkildsen","year":"2022","journal-title":"Rheumatology (United Kingdom)."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s40744-019-00180-9","article-title":"Risk of potential glucocorticoid-related adverse events in patients with Giant cell arteritis: results from a USA-based electronic health records database","volume":"6","author":"Best","year":"2019","journal-title":"Rheumatol Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2021.732934","article-title":"Presentation and real-world Management of Giant Cell Arteritis (Artemis study)","volume":"8","author":"Mahr","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae107","article-title":"The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations","author":"Therkildsen","year":"2024","journal-title":"Rheumatology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3899\/jrheum.2022-1214","article-title":"Relapse risk and safety of long-term Tocilizumab use among patients with Giant cell arteritis: a single-enterprise cohort study","volume":"50","author":"Samec","year":"2023","journal-title":"J Rheumatol"},{"key":"ref31","first-page":"112","article-title":"Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice","volume":"124","author":"Calder\u00f3n-Goercke","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.55563\/clinexprheumatol\/oqs8u9","article-title":"Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients","volume":"41","author":"Calder\u00f3n-Goercke","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02529-4","article-title":"Assessment of the efficacy and safety of tocilizumab in patients over 80 years health and care evidence, from health education England","volume":"23","author":"de Boysson","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rap\/rkaa017","article-title":"Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients","volume":"4","author":"Regola","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1056\/NEJMoa2303452","article-title":"Sarilumab for relapse of polymyalgia Rheumatica during glucocorticoid taper","volume":"389","author":"Spiera","year":"2023","journal-title":"N Engl J Med [Internet]"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jama.2022.15459","article-title":"Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial","volume":"328","author":"Devauchelle-Pensec","year":"2022","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/annrheumdis-2021-221126","article-title":"Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2\/3 randomised controlled trial","volume":"81","author":"Bonelli","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1093\/rheumatology\/kead028","article-title":"Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study","volume":"62","author":"Nielsen","year":"2023","journal-title":"Rheumatology"},{"key":"ref39","first-page":"1321","article-title":"Association between vascular 18F-Fluorodeoxyglucose uptake at diagnosis and change in aortic dimensions in Giant cell arteritis","volume-title":"Ann Intern Med","author":"Moreel","year":"2023"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"S0953-6205(24)00145-6","DOI":"10.1016\/j.ejim.2024.03.037","article-title":"Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: an observational restrospective study","volume":"7","author":"Billet","year":"2024","journal-title":"Eur J Intern Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"keae260","DOI":"10.1093\/rheumatology\/keae260","article-title":"The OMERACT giant cell arteritis ultrasonography score: a potential predictive outcome to assess the risk of relapse during follow-up","volume":"8","author":"Molina-Collada","year":"2024","journal-title":"Rheumatology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/annrheumdis-2013-204113","article-title":"The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.semarthrit.2020.11.003","article-title":"Prevalence and prognostic factors for aortic dilatation in giant cell arteritis \u2013 a longitudinal study","volume":"51","author":"Jud","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.semarthrit.2018.10.003","article-title":"Aortic dilatation in patients with large vessel vasculitis: a longitudinal case control study using PET\/CT","volume":"48","author":"Muratore","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1093\/rheumatology\/keab871","article-title":"Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study","volume":"61","author":"Therkildsen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard-2022-223429","article-title":"Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica","volume":"83","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e019325","DOI":"10.1136\/bmjopen-2017-019325","article-title":"Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study","volume":"8","author":"Kringelbach","year":"2018","journal-title":"BMJ Open"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica-a prospective study of 101 patients","author":"Nielsen","year":"","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref52","first-page":"152069","volume-title":"Sem Arthritis Rheumatism","author":"Nielsen","year":"2022"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"152017","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica a systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-017-1374-1","article-title":"Settings and artefacts relevant for Doppler ultrasound in large vessel vasculitis","volume":"19","author":"Terslev","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e000598","DOI":"10.1136\/rmdopen-2017-000598","article-title":"Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT large vessel vasculitis ultrasound working group","volume":"4","author":"Chrysidis","year":"2018","journal-title":"RMD Open"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(a) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET interest group (PIG), and endorsed by the ASNC","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"107574","DOI":"10.1016\/j.carpath.2023.107574","article-title":"Consensus statement on the processing, interpretation and reporting of temporal artery biopsy for arteritis","volume":"67","author":"Nair","year":"2023","journal-title":"Cardiovasc Pathol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-11-83","volume-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of patients","author":"Thygesen","year":"2011"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.2010.135129","article-title":"European league against rheumatism recommendations for the inclusion of patient representatives in scientific projects","volume":"70","author":"De Wit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152172","article-title":"Prognostic factors in giant cell arteritis associated aortitis with PET\/CT and CT angiography at diagnosis","volume":"152172","author":"Genin","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1759720X2110090","DOI":"10.1177\/1759720X211009029","article-title":"Large-vessel involvement is predictive of multiple relapses in giant cell arteritis","volume":"13","author":"de Mornac","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3899\/jrheum.181127","article-title":"Factors associated with relapse and dependence on glucocorticoids in giant cell arteritis","volume":"47","author":"Dumont","year":"2020","journal-title":"J Rheumatol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13075-020-02171-6","article-title":"Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions","volume":"22","author":"Sugihara","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"152051","DOI":"10.1016\/j.semarthrit.2022.152051","article-title":"Association of ultrasound-confirmed axillary artery vasculitis and clinical outcomes in giant cell arteritis","volume":"56","author":"Bosch","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/rheumatology\/ken258","article-title":"Prognosis of large-vessel giant cell arteritis","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/03009742.2021.1889025","article-title":"Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study","volume":"51","author":"Tomelleri","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.amjmed.2017.03.054","article-title":"Giant-cell arteritis: do we treat patients with large-vessel involvement differently?","volume":"130","author":"de Boysson","year":"2017","journal-title":"Am J Med"},{"key":"ref70","first-page":"3710","article-title":"Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis? Rheumatology (United Kingdom)","author":"Esperan\u00e7a Almeida","year":"2023"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.semarthrit.2015.06.009","article-title":"Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica","volume":"45","author":"Narv\u00e1ez","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MD.0b013e318145275c","article-title":"Development of ischemic complications in patients with Giant cell arteritis presenting with apparently isolated polymyalgia Rheumatica","volume":"86","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2007","journal-title":"Medicine"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/art.42290","article-title":"Association of 18F-Fluorodeoxyglucose\u2013positron emission tomography activity with angiographic progression of disease in large vessel Vasculitis","volume":"75","author":"Quinn","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1093\/rheumatology\/kead081","article-title":"Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure","volume":"62","author":"Bridgewater","year":"2023","journal-title":"Rheumat (Oxford)"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/rheumatology\/kead201","article-title":"Validation of a patient-reported outcome measure for giant cell arteritis","volume":"63","author":"Ndosi","year":"2024","journal-title":"Rheumatology"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine"}],"updated-by":[{"DOI":"10.3389\/fmed.2026.1833528","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1415076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:33:09Z","timestamp":1774971189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1415076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":78,"alternative-id":["10.3389\/fmed.2024.1415076"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1415076","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"article-number":"1415076"}}